Vir Biotechnology, Inc.
VIR
$5.09
-$0.325-6.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 801.66M | 905.35M | 914.47M | 1.15B | 1.15B |
| Total Receivables | 5.40M | 5.10M | 5.30M | 7.20M | 4.10M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 36.99M | 42.63M | 37.79M | 33.53M | 45.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 88.15M | 89.39M | 89.60M | 13.95M | 13.34M |
| Total Current Assets | 932.21M | 1.04B | 1.05B | 1.21B | 1.21B |
|
|
|||||
| Total Current Assets | 932.21M | 1.04B | 1.05B | 1.21B | 1.21B |
| Net Property, Plant & Equipment | 120.24M | 122.86M | 125.57M | 128.33M | 162.82M |
| Long-term Investments | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Goodwill | 16.94M | 16.94M | 16.94M | 16.94M | 16.94M |
| Total Other Intangibles | 8.07M | 8.12M | 19.26M | 18.90M | 22.47M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.13M | 18.42M | 17.94M | 19.66M | 18.92M |
| Total Assets | 1.31B | 1.40B | 1.50B | 1.67B | 1.79B |
|
|
|||||
| Total Accounts Payable | 3.73M | 5.08M | 7.31M | 4.39M | 7.11M |
| Total Accrued Expenses | 85.02M | 66.53M | 65.53M | 48.21M | 52.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.93M | 7.75M | 19.41M | 19.50M | 11.91M |
| Total Finance Division Other Current Liabilities | 40.61M | 40.30M | 24.92M | 24.32M | 22.44M |
| Total Other Current Liabilities | 40.61M | 40.30M | 24.92M | 24.32M | 22.44M |
| Total Current Liabilities | 137.29M | 119.66M | 117.16M | 96.41M | 94.07M |
|
|
|||||
| Total Current Liabilities | 137.29M | 119.66M | 117.16M | 96.41M | 94.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 88.17M | 90.14M | 93.41M | 95.02M | 109.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 38.45M | 38.63M | 47.06M | 44.46M | 43.37M |
| Total Liabilities | 263.91M | 248.43M | 257.63M | 235.89M | 246.61M |
|
|
|||||
| Common Stock & APIC | 1.93B | 1.91B | 1.89B | 1.88B | 1.85B |
| Retained Earnings | -880.75M | -759.78M | -655.20M | -441.48M | -303.10M |
| Treasury Stock & Other | -1.98M | -1.72M | 1.13M | -2.88M | -2.40M |
| Total Common Equity | 1.04B | 1.15B | 1.24B | 1.43B | 1.55B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04B | 1.15B | 1.24B | 1.43B | 1.55B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04B | 1.15B | 1.24B | 1.43B | 1.55B |
|
|
|||||